Skip to main content

Table 6 Antimicrobial susceptibility of Pseudomonas and Acinetobacter species

From: Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients

 

Pseudomonas species

Acinetobacter species

Antibiotic

B

S

I

R

B

S

I

R

Amikacin

32

44.2

3.9

51.9

32

44.9

6.1

49

Amp-Sul*

16/8

37

10

53

16/8

35.9

12.8

51.3

Aztereonam

16

10.5

7.9

81.6

16

10

12.5

77.5

Cefepime

16

38.9

5.6

55.6

16

25

12.5

62.5

Cefopyrazon

32

13.2

0

86.8

32

11.4

0

88.6

Cefotaxime

16

4.3

10.6

85.1

32

11.1

15.6

73.3

Cefotetan

32

25

12.5

62.5

32

36.5

4.5

59

Ceftazidime

16

28

2

70

16

29

5

66

Ceftizoxime

32

2.9

11.4

85.7

32

17.7

5.9

76.5

Ceftriaxone

16

4.1

16.3

79.6

32

23.9

15.2

60.9

Ciprofloxacin

2

42.3

3.9

53.9

2

52.1

4.2

43.8

Gentamicin

8

35.9

11.3

52.8

4

42.6

4.3

53.2

Imipenem

8

54

6

40

8

54.6

4.6

40.9

Levofloxacin

4

51.9

1.9

46.2

4

58.7

2.2

39.1

Meropenem

8

50.9

11.3

37.7

8

55

5

40

Mezlocillin

64

6.9

0

93

64

7

0

93

Netilmicin

16

30.6

13.9

55.6

16

53.1

6.3

40.6

Piperacillin

64

10.5

2.6

86.8

64

15.4

15.4

69.2

Pip-Taz**

32

40

6.7

53.3

64

47.7

6.8

45.5

Sul-Tri***

16

40

0

60

16

41.3

0

58.7

Tetracycline

8

21.1

10.5

68.4

8

36.4

6.1

57.6

Ticarcillin

64

8.3

0

91.7

64

21.2

12.1

66.7

Tic-Cla****

64

24.5

4.1

71.4

64

17.1

14.6

68.3

Tobramycin

8

52.8

1.9

45.3

8

54.4

2.2

43.5

  1. B = Breakpoint S = Susceptible I = Intermediate R = Resistant
  2. *Ampicillin-Sulbactam **Piperacillin-Tazobactam *** Sulfamethoxazole- Trimethoprim **** Ticarcillin/Clavulanate